Alkermes earnings were $352.7M for the trailing 12 months ending Mar 31, 2025, with -17.9% growth year over year. The latest ALKS earnings report on Mar 31, 2025 announced Q1 2025 earnings of $22.5M, down 84.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ALKS reported annual earnings of $367.1M, with 3.2% growth. The next ALKS earnings date is Jul 22, 2025.
ALKS past earnings growth
How has ALKS's earnings growth performed historically?
On ALKS's earnings call on Invalid Date, Alkermes (NASDAQ: ALKS) reported Q1 2025 earnings per share (EPS) of $0.14, up 36.36% year over year. Total ALKS earnings for the quarter were $22.46 million. In the same quarter last year, Alkermes's earnings per share (EPS) was $0.22.
The next ALKS earnings call is Invalid Date. Add ALKS to your watchlist to be reminded of Alkermes's next earnings date.
Is Alkermes profitable or losing money?
As of the last Alkermes earnings report, Alkermes is currently profitable. Alkermes's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $352.71 million, a 18.81% decrease year over year.
What was ALKS's earnings growth in the past year?
As of Alkermes's earnings date in Invalid Date, Alkermes's earnings has grown -17.94% year over year. This is 19.18 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 1.24%. ALKS earnings in the past year totalled $352.71 million.
What are Alkermes's earnings expectations?
The current EPS estimate for Alkermes's earnings report in Invalid Date is $0.38.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.